Abnormal brain diffusivity in patients with neuropsychiatric systemic lupus erythematosus.

BACKGROUND AND PURPOSE Neuroimaging techniques have increased our knowledge of the pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE) and have been useful in supporting the diagnosis. Nevertheless, new imaging techniques are needed to unravel the exact pathogenesis and to provide diagnostic criteria for NPSLE. In this preliminary study, we investigated whether diffusion-weighted imaging (DWI) can depict cerebral abnormalities in patients with a history of NPSLE, and we assessed whether apparent diffusion coefficient (ADC) histograms in these patients differ from those of healthy control subjects. METHODS Eleven female patients with a history of NPSLE (mean age [+/- SD], 35 years +/- 9) and 10 healthy control subjects (eight female, two male; mean age, 37 years +/- 16) underwent DWI. DWI and ADC images were assessed by means of visual inspection, and histograms were composed from the ADC images. From these, we derived a variety of parameters that quantitatively reflect the diffusivity of brain parenchyma. RESULTS Visual inspection of ADC images and DWIs did not reveal any abnormalities in either patients with NPSLE or control subjects. In contrast, ADC histograms of the NPSLE group were, on average, significantly lower and broader, with a higher mean ADC value. CONCLUSION The data suggest an increased general diffusivity in brain parenchyma of patients with NPSLE, probably based on loss of tissue integrity. In addition to increasing our battery of highly wanted diagnostic tools and our understanding of the pathogenesis of NPSLE, the present method seems to be useful in quantifying the disease burden, enabling monitoring in treatment trials and the study of disease progression.

[1]  A. Pupi,et al.  Regional cerebral blood flow in juvenile systemic lupus erythematosus: a prospective SPECT study. Single photon emission computed tomography. , 1998, The Journal of rheumatology.

[2]  F. Quismorio,et al.  Magnetic resonance imaging of the brain in neuropsychiatric systemic lupus erythematosus. , 1993, Seminars in arthritis and rheumatism.

[3]  J. Gómez-Reino,et al.  Magnetic resonance imaging of the brain in systemic lupus erythematosus. , 1995, British journal of rheumatology.

[4]  E. Richardson,et al.  The neurological manifestations of systemic lupus erythematosus. , 1968, Medicine.

[5]  I. Wilkinson,et al.  Magnetic resonance imaging of the brain and cerebral proton spectroscopy in patients with systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[6]  E. Nitzsche,et al.  Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study , 1997, European Journal of Nuclear Medicine.

[7]  A. Zwinderman,et al.  Evidence of central nervous system damage in patients with neuropsychiatric systemic lupus erythematosus, demonstrated by magnetization transfer imaging. , 2000, Arthritis and rheumatism.

[8]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[9]  A. Aisen,et al.  Identification of brain lesions in neuropsychiatric systemic lupus erythematosus by magnetic resonance scanning. , 1988, Arthritis and rheumatism.

[10]  R. Travers,et al.  OXYGEN-15 BRAIN SCANNING FOR DETECTION OF CEREBRAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS , 1978, The Lancet.

[11]  H. Mamo,et al.  Cerebral blood flow in systemic lupus erythematosus with and without central nervous system involvement. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[12]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[13]  M. van Buchem,et al.  Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. , 2000, Arthritis and rheumatism.

[14]  W. Brooks,et al.  Neuroimaging in neuropsychiatric systemic lupus erythematosus. , 1999, Arthritis and rheumatism.

[15]  J. Kucharczyk,et al.  Diffusion/perfusion MR imaging of acute cerebral ischemia , 1991, Magnetic resonance in medicine.

[16]  A. Hovestadt,et al.  Single-photon-emission computed tomography of the brain in the evaluation of cerebral lupus. , 2010, Arthritis and rheumatism.

[17]  N. Zvaifler,et al.  The pathogenesis of central nervous system manifestations of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[18]  M Fisher,et al.  New magnetic resonance techniques for acute ischemic stroke. , 1995, JAMA.

[19]  S Porter,et al.  Magnetic resonance imaging abnormalities and cognitive deficits in systemic lupus erythematosus patients without overt central nervous system disease. , 1998, Arthritis and rheumatism.

[20]  M. Verity,et al.  Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955--1977. , 1979, Seminars in arthritis and rheumatism.

[21]  G. Barker,et al.  Proton magnetic resonance spectroscopy of systemic lupus erythematosus involving the central nervous system , 1995, Journal of Neurology.

[22]  O. Schober,et al.  Positron emission tomography in neuropsychiatric lupus erythematosus , 1990, Neurology.

[23]  D. Gladman,et al.  The use of single photon emission computerized tomography in neuropsychiatric SLE: a pilot study. , 1995, Journal of Rheumatology.

[24]  J. Hanly,et al.  Brain pathology in systemic lupus erythematosus. , 1992, The Journal of rheumatology.

[25]  O. Devinsky,et al.  Clinical and neuropathological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli, and thrombotic thrombocytopenic purpura , 1988, Annals of neurology.

[26]  P. Chieng,et al.  The role of FDG-PET, HMPAO-SPET and MRI in the detection of brain involvement in patients with systemic lupus erythematosus , 1999, European Journal of Nuclear Medicine.

[27]  M. Reivich,et al.  Cerebral blood flow in systemic lupus erythematosus with or without cerebral complications , 1987, Neurology.

[28]  R. Griffey,et al.  Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. , 1990, Arthritis and rheumatism.

[29]  M S Buchsbaum,et al.  Whole-brain diffusion MR histograms differ between MS subtypes , 2000, Neurology.

[30]  P. V. van Zijl,et al.  Neurochemistry of brain lesions determined by spectroscopic imaging in systemic lupus erythematosus. , 1997, The Journal of rheumatology.

[31]  Wei Li,et al.  Fast magnetic resonance diffusion‐weighted imaging of acute human stroke , 1992, Neurology.

[32]  W. Mccune,et al.  Neuropsychiatric lupus. , 1988, Rheumatic diseases clinics of North America.